GUANACLINE SULFATE ANHYDROUS

OS(O)(=O)=O.CC1=CCN(CCNC(N)=N)CC1

InChIKey=FLZPKJNDZPCKJG-UHFFFAOYSA-N

InChI=1S/C9H18N4.H2O4S/c1-8-2-5-13(6-3-8)7-4-12-9(10)11;1-5(2,3)4/h2H,3-7H2,1H3,(H4,10,11,12);(H2,1,2,3,4)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Guanacline was studied in the treatment of hypertension. However, information about the current use of this compound is not available.

PubMed

Title	Date	PubMed
Guanacline, a new hypotensive drug.	1969 Jan 25	5779041
Clinical experiences with Leron (guanacline) in the treatment of hypertension.	1970 May 9	5420832
Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline).	1986 Sep 24	3768685

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:05:10 GMT 2023` Edited by `admin` on `Fri Dec 15 15:05:10 GMT 2023`
Record UNII	UE69UT7F2Y
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

GUANACLINE SULFATE ANHYDROUS

Common Name

English

GUANACLINE SULPHATE ANHYDROUS

Common Name

English

Guanacline sulfate anhydrous [WHO-DD]

Common Name

English

GUANACLINE MONOSULFATE [MI]

Common Name

English

Code System Code Type Description

ECHA (EC/EINECS)

216-344-1